Bill joined the Wyss Institute in 2021. He works with the visionary scientists, engineers, and staff of the Institute to translate deep technologies into commercial ventures. Prior to the Wyss, Bill served as a strategy consultant to life sciences companies spanning biotechnology start-ups to Fortune 500 pharmaceutical firms. He holds a Ph.D. in chemical engineering from Cornell University.